LPCAT3 antibody (AA 306-363)

Catalog No. ABIN7158760

Product Details anti-LPCAT3 Antibody

Target: LPCAT3 (Lysophosphatidylcholine Acyltransferase 3 (LPCAT3))

Binding Specificity: AA 306-363

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This LPCAT3 antibody is un-conjugated

Application: Immunohistochemistry (IHC), ELISA

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Lysophospholipid acyltransferase 5 protein (306-363AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: IHC:1:20-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for LPCAT3

Target: LPCAT3 (Lysophosphatidylcholine Acyltransferase 3 (LPCAT3))

Alternative Name: LPCAT3 (LPCAT3 Products)

Synonyms: c3f antibody, lpcat antibody, lpcat3 antibody, lpsat antibody, mboat5 antibody, nessy antibody, oact5 antibody, MBOAT5 antibody, Grcc3f antibody, Mboat5 antibody, Oact5 antibody, C3F antibody, LPCAT antibody, LPLAT 5 antibody, LPSAT antibody, OACT5 antibody, C3f antibody, Lpcat antibody, Lpeat antibody, Lplat5 antibody, Lpsat antibody, Moact5 antibody, PTG antibody, GRCC3F antibody, lysophosphatidylcholine acyltransferase 3 S homeolog antibody, lysophosphatidylcholine acyltransferase 3 antibody, lpcat3.S antibody, LPCAT3 antibody, lpcat3 antibody, Lpcat3 antibody

Background:

Background: Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle.

Aliases: 1-acylglycerophosphocholine O-acyltransferase antibody, 1-acylglycerophosphoserine O-acyltransferase antibody, LPCAT antibody, Lpcat3 antibody, LPLAT 5 antibody, LPSAT antibody, Lyso-PC acyltransferase 3 antibody, Lyso-PC acyltransferase antibody, Lyso-PS acyltransferase antibody, Lysophosphatidylcholine acyltransferase 3 antibody, Lysophosphatidylcholine acyltransferase antibody, Lysophosphatidylserine acyltransferase antibody, Lysophospholipid acyltransferase 5 antibody, MBOA5 antibody, MBOA5_HUMAN antibody, Membrane-bound O-acyltransferase domain-containing protein 5 antibody, O-acyltransferase domain-containing protein 5 antibody

UniProt: Q6P1A2